Header cover image
  • Investing Ideas
  • /
  • Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Xiamen Amoytop Biotech

Market Cap: CN¥29.9b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥75.00

7D

-1.6%

1Y

26.1%